$74bn Pharmaceutical Merger Announced By Bristol Myers & Celgene
A block buster and record making merger has been announced by two of the biggest drug companies of the United States. Drug maker Celgene would be taken over by Bristol-Myers Squibb in a cash and stock deal including debt and the value of the deal as announced is worth about between $74bn and $90bn. The…









